Cryo Cell International (CCEL) Operating Expenses (2010 - 2026)

Cryo Cell International (CCEL) has 17 years of Operating Expenses data on file, last reported at $6.9 million in Q1 2026.

• Operating Expenses for Q1 2026 came in at $6.9 million, changed 0.07% year-over-year; the trailing twelve-month figure through Feb 2026 was $31.1 million (up 9.52% YoY), and the FY2025 annual result was $31.1 million, up 9.04% from the prior year.
• Operating Expenses fell to $6.9 million in Q1 2026 per CCEL's latest filing, from $11.8 million in the prior quarter.
• Over five years, Operating Expenses peaked at $24.1 million in Q4 2023 and troughed at $5.8 million in Q1 2022.
• A 5-year average of $8.0 million and a median of $6.7 million in 2022 frame the typical range for Operating Expenses.
• The sharpest annual moves came in 2023 and 2024: Operating Expenses soared 226.86% in 2023, then sank 66.13% in 2024.
• A 5-year view of Operating Expenses shows it stood at $7.4 million in 2022, then soared by 226.86% to $24.1 million in 2023, then plunged by 66.13% to $8.1 million in 2024, then surged by 44.97% to $11.8 million in 2025, then tumbled by 41.42% to $6.9 million in 2026.
• Business Quant data shows CCEL's Operating Expenses at $6.9 million in Q1 2026, $11.8 million in Q4 2025, and $5.9 million in Q3 2025.